Scarica l'app Stockscreener
20.03
6.71%
-1.44
Dopo l'orario di chiusura:
19.00
-1.03
-5.14%
Cue Biopharma Inc Borsa (CUE) Ultime notizie
CUE stock on track for best day in history — why is retail optimistic? - MSN
Cue Biopharma Analyst Ratings and Price Targets | NASDAQ:CUE - Benzinga
Cue Biopharma Inc stock (US22966J1060): capital raise, pipeline focus and conference spotlight - AD HOC NEWS
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times
Cue Biopharma CEO to present at Jefferies healthcare conference in NYC - Stock Titan
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference | Associated Press | syndication news - Enidnews.com
Major dilution on table as Cue Biopharma (CUE) asks holders to OK warrants and 2026 plan - Stock Titan
MSN Money - MSN
Cue Biopharma Company Profile & Introduction - Moomoo
Cue Biopharma Inc stock (US22966J1060): cancer immunotherapy hopes meet volatile share price - AD HOC NEWS
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments - The Manila Times
Cue Biopharma earnings beat by $2.22, revenue topped estimates - Investing.com Canada
Cue Biopharma receives $7.5M milestone payment from Boehringer Ingelheim - MSN
Cue Biopharma reports Q1 loss, secures $30M financing - Investing.com UK
CUE Financials: Income Statement, Balance Sheet & Cash Flow | Cue Biopharma Inc - Stock Titan
Cue Biopharma reports Q1 loss, secures $30M financing By Investing.com - Investing.com Nigeria
Cue Biopharma (CUE) boosts Q1 revenue, raises $30M and trims net loss - Stock Titan
[10-Q] Cue Biopharma, Inc. Quarterly Earnings Report - Stock Titan
Press Release: Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments - Moomoo
Cue Biopharma stock (US22966J1060): Analysts set $4 average price target - AD HOC NEWS
Cue Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Cue Biopharma, Inc. announced that it has received $29.999992 million in funding - marketscreener.com
CUE Stock Chart | CUE BIOPHARMA INC (NASDAQ:CUE) - ChartMill
Cue Biopharma (NASDAQ: CUE) asks shareholders to approve 4.64M warrant shares, 2026 equity plan - Stock Titan
TradingKey - TradingKey
Wall Street Zen Upgrades Cue Biopharma (NASDAQ:CUE) to Strong-Buy - MarketBeat
What's behind the drop in Cue Biopharma stock today? - MSN
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Cue Biopharma Inc. R (1UC0.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cue Biopharma Grants Inducement Equity Awards to New Executive and Employees - Quiver Quantitative
New Cue Biopharma CEO gets 655,074-share option and 327,537 stock units - Stock Titan
Cue Biopharma, Inc. Common Stock (CUE) Stock Price Today & Analysis - Gotrade
Cue Biopharma (CUE) CEO Shao-Lee Lin submits initial Form 3 - Stock Titan
Cue Biopharma (CUE) CEO granted 327,537 shares and 655,074 options - Stock Titan
Number of shareholders of Cue Biopharma, Inc. – NASDAQ:CUE - TradingView
Number of shareholders of Cue Biopharma, Inc. – DUS:1UC0 - TradingView
Cue Biopharma, Inc. Dividends – DUS:1UC0 - TradingView
Cue Biopharma(CUE) Stock Options Chain | Quotes & News - Moomoo
Cue Biopharma (CUE) price target increased by 2,900.00% to 122.40 - MSN
Cue Biopharma (NASDAQ:CUE) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
0.98%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):